Article
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
Journal of medical virology - 1 May 2024
Chang Yu-Ping, Huang Chiuan-Bo, Su Tung-Hung, Liu Chun-Jen, Tseng Tai-Chung, Huang Shang-Chin, Chen Pei-Jer, Kao Jia-Horng, Liu Chen-Hua
Abstract excerpt
Comparison of diagnostic accuracy for commercial hepatitis C virus (HCV) genotyping (Abbott RealTime HCV Genotyping II, Roche Cobas Genotyping) and investigational Abbott HCV Genotype plus RUO assays designed to discriminate genotype (GT)-1a, 1b or 6 in cases of ambiguous GT from the Abbott commercial assay remains limited. 743 HCV-viremic samples were subjected to analysis using Abbott and Roche commercial as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
